The International Monetary Fund raised its outlook for economic growth across emerging market and developing economies this ...

Pharma giant Novo Nordisk A/S (NYSE:NVO) is plunging 21% to trade at a nearly three-year low of $54.27, after the company's ...

In its world economic outlook, the IMF lifted its U.S. growth estimate for 2025 to 1.9% and the 2026 forecast to 2%. That’s ...

U.S.-listed shares of Novo Nordisk sank in premarket trading Tuesday after the Danish drugmaker cut its full-year outlook and ...

The IMF now projects India’s growth at 6.4% for both 2025 and 2026, an increase from its previous forecast of 6.2% made in April. In its World Economic Outlook report, the IMF stated that India’s ...

The International Monetary Fund (IMF) on Tuesday slightly upgraded its 2025 and 2026 economic growth forecasts for India, citing a more favourable global economic situation.

Shipowners grapple with OPEC+ supply increases, tensions in the Middle East, and rising numbers of newbuildings.

Novo Nordisk has named Maziar Mike Doustdar, currently the company’s EVP of international operations, as the new CEO.

U.S. growth was expected to reach 1.9% in 2025, up 0.1 percentage point from April's outlook, edging up to 2% in 2026. A new ...

OnlineCheckWriter.com - Powered by Zil Money introduces minutes-long transfers targeting the $38 billion US-India payment ...

Explore in-depth analysis of the North American airline industry, covering postpandemic normalization, airline stock valuation, and emerging trends in demand and pricing, as well as insights on key ...

Novo Nordisk announced company veteran Maziar Mike Doustdar as its next CEO, as the firm struggles to regain its dominance in ...